Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 1,653 shares at $51.45 ($85K) on 2018-05-08, disclosed to the SEC on 2018-05-09.
Open-market sale of $85k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |